1Y Close · As of Aug 26, 2026
LabGenomics operates in the Professional Services sector.
Legal name: LabGenomics. Co., Ltd.
In fiscal year 2025, LabGenomics (084650) reported revenue of 88.2 billion KRW, up 2.6% from 85.9 billion KRW a year earlier.
Operating profit was -53.5 billion KRW and net income was -64.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 45.1 billion KRW, with a P/B of 0.30.
These figures can be verified in the DART filing (receipt no. 20260323001646).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 88.2B | -53.5B | -64.4B |
| 2024 | 85.9B | -18.5B | -23.9B |
| 2023 | 73.1B | -6.8B | -5.2B |
Recent Filings
Trading Halt (Share Consolidation/Split Electronic Change)
전환가액의조정 (제5회차)
Extraordinary Meeting Result
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Trading Halt (Share Consolidation/Split Electronic Change) |
| 2026-08-20 | 전환가액의조정 (제5회차) |
| 2026-08-18 | Extraordinary Meeting Result |
| 2026-08-18 | Independent Director Change Report |
| 2026-08-14 | Semi-Annual Report (2026.06) |